WallStSmart

Amrize Ltd (AMRZ)vsUnited States Lime & Minerals Inc (USLM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Amrize Ltd generates 3126% more annual revenue ($11.91B vs $369.31M). USLM leads profitability with a 35.4% profit margin vs 9.7%. USLM trades at a lower P/E of 23.9x. AMRZ earns a higher WallStSmart Score of 49/100 (D+).

AMRZ

Hold

49

out of 100

Grade: D+

Growth: 4.0Profit: 5.0Value: 5.7Quality: 5.0
Piotroski: 2/9Altman Z: 1.61

USLM

Hold

46

out of 100

Grade: D+

Growth: 4.0Profit: 9.0Value: 5.7Quality: 8.5
Piotroski: 2/9Altman Z: 10.69
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AMRZ.

USLMUndervalued (+5.3%)

Margin of Safety

+5.3%

Fair Value

$113.82

Current Price

$104.61

$9.21 discount

UndervaluedFair: $113.82Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ1 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

USLM4 strengths · Avg: 10.0/10
Profit MarginProfitability
35.4%10/10

Keeps 35 of every $100 in revenue as profit

Operating MarginProfitability
40.7%10/10

Strong operational efficiency at 40.7%

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
10.6910/10

Safe zone — low bankruptcy risk

Areas to Watch

AMRZ4 concerns · Avg: 4.0/10
P/E RatioValuation
25.2x4/10

Moderate valuation

Revenue GrowthGrowth
4.7%4/10

4.7% revenue growth

EPS GrowthGrowth
3.6%4/10

3.6% earnings growth

Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

USLM3 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Revenue GrowthGrowth
-3.7%2/10

Revenue declined 3.7%

EPS GrowthGrowth
-10.9%2/10

Earnings declined 10.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on Price/Book. PEG of 1.42 suggests the stock is reasonably priced for its growth.

Bull Case : USLM

The strongest argument for USLM centers on Profit Margin, Operating Margin, Debt/Equity. Profitability is solid with margins at 35.4% and operating margin at 40.7%.

Bear Case : AMRZ

The primary concerns for AMRZ are P/E Ratio, Revenue Growth, EPS Growth.

Bear Case : USLM

The primary concerns for USLM are Piotroski F-Score, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

AMRZ profiles as a value stock while USLM is a declining play — different risk/reward profiles.

AMRZ is growing revenue faster at 4.7% — sustainability is the question.

USLM generates stronger free cash flow (14M), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AMRZ scores higher overall (49/100 vs 46/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is an innovative technology company at the forefront of the digital health and wellness sector, dedicated to transforming healthcare delivery through advanced technologies and data-driven solutions. With a strong focus on improving patient outcomes and enhancing accessibility, Amrize invests significantly in research and development to meet the growing demand for scalable health innovations. Its strategic initiatives and diverse product offerings position the company as a key player in modern healthcare transformation, presenting a compelling opportunity for institutional investors in a rapidly evolving market.

Visit Website →

United States Lime & Minerals Inc

BASIC MATERIALS · BUILDING MATERIALS · USA

United States Lime & Minerals, Inc. manufactures and supplies lime and limestone products in the United States. The company is headquartered in Dallas, Texas.

Want to dig deeper into these stocks?